Replies to post #171725 on Vivos Inc (RDGL)

[SC8]

There is no correlation to see. FDA needs controlled and monitored animal data to consider Radiogel for human trials. To date, MK has failed to deliver any animal data to FDA. Uncontrolled and unmonitored IsoPet treatments of one off dogs, cats and horses are anecdotes, not data.

Now 5 years post launch, there is no chance of IsoPet becoming profitable within cash runway left. It's a hopeless distraction from only thing that can save RDGL now. RDGL still can't manufacture Radiogel to FDA standards. Clearly Radiogel progress has suffered because of MK's hopeless distraction with hopelessly unprofitable IsoPet.